SYNOPSIS The stability of prothrombin and factor VII was studied using accelerated degradation tests in three preparations of freeze-dried pooled normal plasmas. In a previous report (Brozovic, Gurd, Robertson, and Bangham, 1971) factor X was shown to be relatively unstable in these preparations of freeze-dried plasma: it was calculated that up to 8 % of the original factor X activity would be lost after 10 years at -20°C, up to 54% at 4°C, and up to 90% at room temperature.
During the past several years attempts have been made to devise a generally acceptable method of standardization of one-stage prothrombin times. There is now general agreement that the thromboplastin sensitivity ratio of Biggs and Denson (1967) obtained with characterized thromboplastin preparations can be employed to compare prothrombin time results obtained in different laboratories using different thromboplastin preparations. Another approach has been proposed by Miale and LaFond (1967) . Freeze-dried reference plasmas of determined clotting factor content are used to test the performance of different thromboplastins. It has been suggested that the two approaches might be combined, and characterized thromboplastin used in conjunction with freeze-dried reference plasma preparations to test different thromboplastins in a simplified system, as outlined by Biggs and Bangham (1971) . The long-term stability of both reference thromboplastin and reference plasmas is of the utmost importance if such a system were to be relied upon over a period of years.
Preparations of two thromboplastins, one human and one bovine, were characterized in a collaborative Received for publication 4 March 1971. factors it may be necessary to store freeze-dried study (Bangham, Biggs, Brozovic, and Denson, 1970 ) and shown to be very stable in accelerated degradation tests over a period of two years. The stability of three additional thromboplastins (two rabbit and one human preparations) is currently being studied. Loeliger and colleagues (Loeliger Menwisse-Braun, Buitendijk, Veltkamp, and Hemker, 1970) have shown that pooled normal plasma and pooled plasma from patients stabilized on long-term anticoagulant treatment, stored in small aliquots at -70°C, gives reproducible results over a period of some years. Miale and LaFond (1969) tested their freeze-dried reference plasmas after 10 months' storage (temperature not specified), and showed that little change in prothrombin times occurred.
We have recently studied the stability of factor X in some preparations of freeze-dried plasma and found that factor X activity decreased on storage. When degradation constants were calculated and the loss of potency estimated, it became apparent that up to 8% of the initial factor X activity could be lost in 10 years if the ampoules were stored at -20°C. As much as 50% could be lost at 4°C and about 90 % at 20°C after the same period of time (Brozovic etal, 1971) .
Stability ofprothrombin andfactor VII in freeze-driedplasma
No data on the stability of prothrombin and factor VII in freeze-dried plasma were found in the literature. Preliminary results indicated that prothrombin and factor VII activity also decreased on storage. We have therefore studied the stability of these factors in plasma preparations freeze dried under the optimal conditions used to prepare international standards.
Materials and Methods

FREEZE-DRIED HUMAN PLASMA PREPARATIONS
Three preparations of freeze-dried human plasma, labelled 65/153, 66/355, and 68/413, were used. Each was prepared from a pool of approximately 4 litres of plasma, collected into ACD from 20 donors at the Oxford Blood Transfusion Centre in 1965, 1966, and 1968 respectively. The individual blood donations were promptly centrifuged at 4°C to get rid of cells and then pooled.
The same day the pooled plasma was distributed at room temperature in equal amounts into hard glass ampoules. Vessels used for the plasma were previously rinsed out with sodium citrate; the ampoules were steamed in acid, extensively rinsed with distilled water and citrate, and sterilized by dry heat in a clean oven. Approximately 10-12 hours after the blood had been obtained from the donors the plasma in the ampoules was frozen at -35°C, placed in liquid nitrogen and then freeze-dried as one batch at -35°C. Thereafter the ampoules were fitted with plastic plugs designed to limit gaseous diffusion and subjected to secondary desiccation for 13 days. After the ampoules had been filled with pure dry nitrogen they were sealed by fusion of the glass.
The moisture content was estimated as loss of weight by the material after heating to 56°C over P205 in a vacuum for five hours. The oxygen content of the ampoules was estimated by mass spectrometry. The results obtained for the three plasmas are shown in Table I 
PROTHROMBIN DETERMINATIONS
The prothrombin content of the three plasmas was measured by a modification of the method of Ware and Seegers (1949) . The reaction mixture consisted of 3 parts Michaelis buffer, 2 parts 25 mM CaC12, and 3 parts phenolized freeze-dried human brain thromboplastin reconstituted in distilled water. The bovine factor V used was obtained from Diagnostic Reagents Ltd. Fibrindex thrombin (Ortho Pharmaceutical Ltd) was used to determine the standard curve for each assay.
FACTOR VII DETERMINATIONS
Factor VII was estimated by a one-stage method according to Denson (1967) . An artificial factol VIIdeficient plasma (kindly provided by Dr Swart, Academisch Ziekenhuis, Leiden) and phenolized freeze-dried human brain thromboplastin were used throughout.
ACCELERATED DEGRADATION TESTS
These tests were performed as described by Jeme and Perry (1956 Factor VII activity decreased on storage although to a lesser extent than prothrombin or factor X activity. The estimated loss after 10 years at -20°C would be less than 20%, and at 4°C less than 18% of the original activity as shown in Table V . At room temperature, the plasmas were estimated to lose between 20 and 70% of factor VII activity in 10 years (Table V) . No buffer was added to the three preparations of plasma before freeze-drying. The addition of a buffer, such as N-2 hydroxyethyl-piperazine N-2-ethanesulphonic acid (HEPES), may improve the stability of these factors. HEPES is known to stabilize the pH of the solution after reconstituting the freeze-dried material (Zucker, Cathey, and West, 1970) , but little is known about its effect on the longterm stability of individual factors. Some preliminary results suggest that it improves the stability of factor VIII in freeze-dried plasma on short-term storage at 37°C (Denson, 1970) .
The results of this study indicate that prothrombin and factor X may be insufficiently stable in freeze-dried plasma to allow the use of plasma as long-term reference material for the standardization of the onestage prothrombin time, and that for use as a working standard it should be stored at -20°C, and not at 4°C. Further investigations into the effect of various buffers added to plasma before freeze-drying are needed.
